 Home > Active Ingredient News > Antitumor Therapy > Stroke: Medium and long-term outcomes of reperfusion therapy in cancer patients

Stroke: Medium and long-term outcomes of reperfusion therapy in cancer patients

 Last Update: 2021-05-20
 Source: Internet
 Author: User

Tags

pancreatic cancer association

diatomaceous earth cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Patients with acute stroke usually have comorbidities, such as active cancer.

Stroke, medsci.

The researchers used the national reperfusion therapy registry to compare the treatment effects of patients receiving reperfusion therapy.

Among the 1338 patients who received reperfusion therapy, 62 (4.

However, compared with the other groups, they had similar 24-hour neurological improvements and adverse events, including cerebral hemorrhage.

It can be seen that in patients with active cancer, reperfusion therapy has similar adverse events and short-term outcomes to other groups.

In patients with active cancer, reperfusion therapy has similar adverse events and short-term outcomes to other groups.

Original source:

Joonsang Yoo.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.